Bruce Kirkham

12.2k total citations · 4 hit papers
143 papers, 7.2k citations indexed

About

Bruce Kirkham is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Bruce Kirkham has authored 143 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Rheumatology, 64 papers in Immunology and 47 papers in Hematology. Recurrent topics in Bruce Kirkham's work include Rheumatoid Arthritis Research and Therapies (66 papers), Psoriasis: Treatment and Pathogenesis (55 papers) and Spondyloarthritis Studies and Treatments (49 papers). Bruce Kirkham is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (66 papers), Psoriasis: Treatment and Pathogenesis (55 papers) and Spondyloarthritis Studies and Treatments (49 papers). Bruce Kirkham collaborates with scholars based in United Kingdom, United States and Australia. Bruce Kirkham's co-authors include Iain B. McInnes, Arthur Kavanaugh, Leonie S. Taams, Philip J. Mease, Luminita Pricop, Shephard Mpofu, S. P. Oakley, Proton Rahman, Paul Bird and Désirée van der Heijde and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Bruce Kirkham

138 papers receiving 7.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial

2015 650 citations Iain B. McInnes, Philip J. Mease et al. profile →
Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis

2015 572 citations Philip J. Mease, Iain B. McInnes et al. profile →
Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: Results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)

2005 502 citations Arthur Kavanaugh, Bruce Kirkham et al. profile →
Enthesitis: from pathophysiology to treatment

2017 326 citations Georg Schett, Bruce Kirkham et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bruce Kirkham United Kingdom	38	4.1k	3.9k	2.1k	717	656	143	7.2k
Thasia Woodworth United States	37	4.2k 1.0×	2.3k 0.6×	1.5k 0.7×	936 1.3×	455 0.7×	84	7.4k
Atul Deodhar United States	50	6.8k 1.7×	5.0k 1.3×	2.8k 1.4×	382 0.5×	627 1.0×	307	9.1k
Christian Antoni Germany	32	5.7k 1.4×	4.4k 1.1×	2.9k 1.4×	508 0.7×	634 1.0×	49	9.3k
Francesco Ciccia Italy	43	3.1k 0.8×	2.9k 0.7×	1.7k 0.8×	750 1.0×	526 0.8×	232	7.1k
Raffaele Scarpa Italy	44	4.0k 1.0×	3.1k 0.8×	1.6k 0.8×	612 0.9×	520 0.8×	226	6.3k
Juan D. Cañete Spain	45	3.8k 0.9×	2.7k 0.7×	1.5k 0.7×	310 0.4×	296 0.5×	218	6.0k
G Triolo Italy	41	2.3k 0.6×	2.1k 0.5×	1.3k 0.6×	671 0.9×	390 0.6×	209	5.7k
Axel J. Hueber Germany	39	2.4k 0.6×	2.7k 0.7×	846 0.4×	742 1.0×	435 0.7×	155	5.9k
Alain Cantagrel France	44	5.3k 1.3×	2.0k 0.5×	1.9k 0.9×	525 0.7×	201 0.3×	202	7.5k
Rieke Alten Germany	45	6.5k 1.6×	3.3k 0.8×	2.7k 1.3×	566 0.8×	187 0.3×	221	9.6k

Countries citing papers authored by Bruce Kirkham

Since Specialization

Citations

This map shows the geographic impact of Bruce Kirkham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce Kirkham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce Kirkham more than expected).

Fields of papers citing papers by Bruce Kirkham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce Kirkham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce Kirkham. The network helps show where Bruce Kirkham may publish in the future.

Co-authorship network of co-authors of Bruce Kirkham

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce Kirkham. A scholar is included among the top collaborators of Bruce Kirkham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce Kirkham. Bruce Kirkham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Durham, Lucy E., Frances Humby, Nora Ng, et al.. (2025). Linking Skin and Joint Inflammation in Psoriatic Arthritis through Shared CD8 ⁺ T Cell Clones. Arthritis & Rheumatology. 78(1). 152–165. 2 indexed citations

Meridor, Katya, Jane Freeston, Philip Laws, et al.. (2025). Development of a PsA-like presentation under anti-IL-13 therapy with tralokinumab for atopic dermatitis. Lara D. Veeken. 65(3).

Norton, Sam, Franziska Denk, Stephen B. McMahon, et al.. (2024). A randomised controlled trial of the effect of intra-articular lidocaine on pain scores in inflammatory arthritis. Pain. 165(11). 2578–2585. 4 indexed citations

Garrood, Toby, et al.. (2024). Pain sensitisation and joint inflammation in patients with active rheumatoid arthritis. RMD Open. 10(1). e003784–e003784. 6 indexed citations

Williams, Ruth, et al.. (2024). Comparative analysis of centrally mediated and inflammatory pain experiences amongst patients diagnosed with rheumatoid arthritis: A multimethods study. Health Expectations. 27(3). e14090–e14090. 1 indexed citations

Hughes, Catherine, et al.. (2024). Unintended Consequences of Immune Therapy for Immune-Mediated Diseases: Paradoxical Psoriasis and Dupilumab-Associated Musculoskeletal Syndrome. The Journal of Rheumatology. 51(Suppl 2). 70–73.

Hughes, Catherine, Joseph P. Nathan, Andrew Pink, et al.. (2023). Characterization of a Musculoskeletal Syndrome of Enthesitis and Arthritis in Patients With Atopic Dermatitis Treated With Dupilumab, an Interleukin‐4/13 Inhibitor. Arthritis & Rheumatology. 75(10). 1793–1797. 13 indexed citations

Povoleri, Giovanni A. M., Lucy E. Durham, Elizabeth H. Gray, et al.. (2023). Psoriatic and rheumatoid arthritis joints differ in the composition of CD8+ tissue-resident memory T cell subsets. Cell Reports. 42(5). 112514–112514. 30 indexed citations

Al‐Mossawi, Hussein, Paul Bowness, Anne Francis, et al.. (2023). Optimising psoriatic arthritis therapy with immunological methods to increase standard evaluation: the protocol of an open-label multicentre, parallel-group, two-arm randomised controlled study evaluation precision medicine approach in the treatment of psoriatic arthritis. BMJ Open. 13(9). e078539–e078539. 5 indexed citations

10.

Norton, Sam, et al.. (2023). A systematic review and meta-analysis of questionnaires to screen for pain sensitisation and neuropathic like pain in inflammatory arthritis. Seminars in Arthritis and Rheumatism. 61. 152207–152207. 14 indexed citations

11.

Pournara, Effie, Matthías Kormáksson, Peter Nash, et al.. (2021). Clinically relevant patient clusters identified by machine learning from the clinical development programme of secukinumab in psoriatic arthritis. RMD Open. 7(3). e001845–e001845. 20 indexed citations

12.

Coates, Laura C., Philip J. Mease, Laure Gossec, et al.. (2018). Minimal Disease Activity Among Active Psoriatic Arthritis Patients Treated With Secukinumab: 2‐Year Results From a Multicenter, Randomized, Double‐Blind, Parallel‐Group, Placebo‐Controlled Phase III Study. Arthritis Care & Research. 70(10). 1529–1535. 37 indexed citations

13.

McInnes, Iain B., Alan Kivitz, Peter Nash, et al.. (2018). SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS: LONG-TERM (4-YEAR) DATA FROM A PHASE 3 STUDY. JCR Journal of Clinical Rheumatology. 25. 1 indexed citations

14.

Mease, Philip J., Laura C. Coates, Bruce Kirkham, et al.. (2016). SECUKINUMAB IMPROVES MINIMAL DISEASE ACTIVITY RESPONSE RATES IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: DATA FROM PHASE 3 FUTURE-2 STUDY. Clinical and Experimental Rheumatology. 34. 777–778. 1 indexed citations

15.

Mease, Philip, Iain B. McInnes, Bruce Kirkham, et al.. (2014). Secukinumab, a Human Anti-Interleukin-17A Monoclonal Antibody, Improves Active Psoriatic Arthritis and Inhibits Radiographic Progression: Efficacy and Safety Data from a Phase 3 Randomized, Multicenter, Double-Blind, Placebo-Controlled Study. Data Archiving and Networked Services (DANS). 66. 12 indexed citations

16.

McInnes, Iain B., Philip J. Mease, Bruce Kirkham, et al.. (2014). Secukinumab, a Human Anti-Interleukin-17A Monoclonal Antibody, Improves Active Psoriatic Arthritis: 24-Week Efficacy and Safety Data from a Phase 3 Randomized, Multicenter, Double-Blind, Placebo-Controlled Study Using Subcutaneous Dosing. Data Archiving and Networked Services (DANS). 66(12). 3529–3529. 19 indexed citations

17.

Gottlieb, Alice B., Philip Mease, Iain B. McInnes, et al.. (2014). Secukinumab, a Human Anti-Interleukin-17A Monoclonal Antibody, Significantly Reduces Psoriasis Burden in Patients with Psoriatic Arthritis: Results from a Phase 3 Randomized Controlled Trial. Queensland's institutional digital repository (The University of Queensland). 66. 12 indexed citations

18.

Osailan, Samira M., Gordon Proctor, Penelope Shirlaw, et al.. (2010). Measurement of mucosal wetness in patients with xerostomia. Oral Diseases. 16(6). 538–538. 1 indexed citations

19.

Bresnihan, Barry, Daniëlle M. Gerlag, Terence Rooney, et al.. (2007). Synovial macrophages as a biomarker of response to therapeutic intervention in rheumatoid arthritis: standardization and consistency across centers.. PubMed. 34(3). 620–2. 58 indexed citations

20.

Korhonen, Timo, Jaro Karppinen, Leena Paimela, et al.. (2006). The Treatment of Disc Herniation-Induced Sciatica With Infliximab. Spine. 31(24). 2759–2766. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact